"International Agency for Research on Cancer" from_date:2012

Cancer surveillance in the Eastern Mediterranean region: a 10-year International Agency for Research on Cancer-WHO Regional Office for the Eastern Mediterranean collaboration. The Eastern Mediterranean region covers a population of more than 700 million individuals and 22 countries and territories, sharing histories, culture, and languages. The countries and territories of this region also have and conflicts. From 2013, the International Agency for Research on Cancer and the WHO Regional Office for the Eastern Mediterranean have been working together to strengthen cancer surveillance to inform regional and national cancer control. Based on an exposition of the cancer patterns, this Policy Review summarises remaining opportunities and barriers in ensuring high-quality cancer surveillance in all WHO

Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews). Before 2005, cancer and other non-communicable diseases were not yet health and development agenda priorities. Since the 2005 World Health Assembly Resolution, which encouraged WHO, the International Agency for Research on Cancer (IARC), and the International Atomic Energy Agency (IAEA) to jointly work on cancer control, progress was achieved in low-income and middle-income countries on a small scale. Recently, rapid acceleration in UN collaboration and global cancer activities has focused attention in global cancer control. This Policy Review presents the evolution of the IAEA, IARC, and WHO joint advisory service

Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis. Li-Fraumeni syndrome is a cancer predisposition syndrome that is associated with a high, lifelong risk of a broad spectrum of cancers that is caused by pathogenic TP53 germline variants. A definition that reflects the broad phenotypic spectrum that has evolved since the gene discovery is lacking, and mechanisms leading to phenotypic differences remain largely unknown. To define the phenotypic spectrum of Li-Fraumeni syndrome and conduct phenotype-genotype associations across the phenotypic spectrum. We analyzed and classified the germline variant data set of the International Agency for Research on Cancer TP53 database

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)

World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015

Coverage of skin cancer and recreational tanning in North American magazines before and after the landmark 2006 International Agency for Research on Cancer report. Skin cancer is an increasingly important global public health problem. Mass media is a key source of skin cancer information. We examined how media coverage of skin cancer has changed over time as a consequence of the release of a key public health report from the International Agency for Research on Cancer (IARC) in 2006, which linked ultraviolet (UV) radiation from indoor tanning and skin cancer. A directed content analysis of skin cancer and tanning coverage in 29 popular North American magazines (2001-2012) examined reporting of skin cancer risk factors, UV behaviors, and early detection in article text (n = 761) and images (n

. Mastocytosis (mast cell disease). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H und Thiele J (Hg.): WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. Lyon: International Agency for Research on Cancer (World Health Organization classification of tumours), 2017; 62–69. Extract of dossier assessment A23-111 Version 1.0 Midostaurin ( systemic

on the Evaluation of Carcinogenic Risks to Humans, World Health Organization, International Agency for Research on Cancer. Lyon, France : Geneva: International Agency for Research on Cancer ; Distributed by WHO Press; 2010. p. 1424. 16. World Health Organization, editor. International Agency for Research on Cancer [Internet]. Lyon; Available from: 17. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko

Agency for Research on Cancer (IARC) has concluded that solar radiation is a cause of melanoma.6 Two systematic reviews focused on the relationship between patterns of sun exposure and risk of melanoma. The first was a high-quality review of case-control studies that concluded intermittent unaccustomed exposure was more important than age at sunburn.7 The second study was a review of ecological recommendations6Cutaneous melanoma3 Prevention, surveillance and genetics 3.1 Introduction Melanoma, especially when diagnosed at an advanced stage, can cause serious morbidity and may be fatal despite treatment. Prevention of the disease, or failing that, minimising its consequences by early detection, are key goals. 3.2 Causation A comprehensive review of evidence by the International

Tissue Sarcomas. London, UK: The Royal College of Pathologists, 2022. Accessed May 2022. Available at: https://www.rcpath.org/uploads/assets/369456b0-f7b4-4631-a0c6d161176f5782/Dataset-for-histopathological-reporting-of-soft-tissue-sarcoma.pdf 7. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours (5th edition, Vol. 3). Lyon, France: International Agency for Research on Cancer

and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017. Eur J Cancer 2017;77:57–74. 3. Elder DE, Massi D, Scolyer RA, Willemze R (eds). WHO Classification of Skin Tumours (4th edition). Lyon, France: International Agency for Research on Cancer, 2018. 4. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th edition). Lyon, France: International Agency for Research on Cancer, 2017. 5. National Institute for Health and Care Excellence. Guideline NG52 Non-Hodgkin’s Lymphoma: Diagnosis and Treatment. Accessed June 2021. Available at: https://www.nice.org.uk/guidance/ng52 6. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al. WHO-EORTC